Targeted Cancer Therapy in China: What to Do When Records Are Missing

Start With the Exact Drug and Biomarker Question

Targeted cancer treatment acts on particular molecular features of a tumour, and biomarker findings can help clinicians assess potential treatment options. That single sentence explains why a records gap is not a vague administrative problem. If the biomarker result is absent, the clinician cannot see which molecular feature was tested, which method was used, or when the sample was taken. If the drug history is absent, the clinician cannot see what has already been tried, at what dose, for how long, and why it stopped.

Before you gather anything, write down the precise question you want answered. Not "is targeted therapy suitable" but something closer to: "My tumour has this reported biomarker result, I have already received these named drugs, and I want to know whether a centre in China can assess my case and how treatment and monitoring would continue." That framing tells the receiving team what to look for and tells you which documents are actually relevant.

A missing record matters differently depending on what it is. A missing pathology block or slide may limit a fresh biomarker assessment. A missing drug timeline may limit any judgement about prior treatment. A missing recent scan may limit staging review. Ask the centre which of these it needs before it can give a meaningful opinion, rather than sending everything you can find.

Which Documents to Request, and From Whom

The pathology report is the foundation. Request the full report, not a summary line, plus the biomarker results it contains and the name and location of the laboratory that issued it. If a biomarker was tested, ask for the method, the date, and whether the original sample or block still exists. Pathology departments, not the oncology clinic, usually hold blocks and slides, so the request may need to go to a different office.

The treatment history is the second pillar. Ask your oncology team for a chronological list of every systemic treatment: drug name, start and stop dates, dose if recorded, reason for stopping, and the response recorded at the time. Discharge summaries and clinic letters often contain this, but they are frequently incomplete. A short letter from the treating oncologist summarising the sequence is more useful than a folder of unrelated notes.

Imaging and laboratory results form the third group. Request the most recent staging scans with their written reports, and the latest blood tests including any tumour marker results your team has been tracking. Ask whether the centre wants images on disc or whether reports alone are acceptable for an initial review. Do not assume a report replaces the images; ask.

If you are unsure who holds a document, work backwards from the test. The hospital that performed it, the laboratory that analysed it, or the clinic that ordered it will normally be able to tell you where the record sits and what their release process requires.

• Pathology report with biomarker results, method and date
• Name and location of the issuing pathology laboratory
• Whether the original sample, block or slide still exists
• Chronological drug list with dates, doses and reasons for stopping
• Most recent staging imaging plus written reports
• Latest blood tests and any tracked tumour marker results

Does a Gap Block the Next Step?

Not necessarily, but it changes what the next step can be. A records-based review can proceed on partial information if the clinician is told clearly what is missing. What it cannot do is produce a confident opinion about a biomarker that was never reported or a treatment line that was never documented. The honest position is that the review may be limited, and the centre should tell you in what way.

This is why you should ask two separate questions. First: can the centre assess my case with the records I have now? Second: if not, which specific document would change that? A useful reply names the missing item rather than asking for "more records". If a centre cannot say which document it needs, that is itself information about how specific its review will be.

A preliminary reply is not a decision. It may confirm that the case is within the centre's scope, or it may say that more information is needed before any view is possible. Neither outcome establishes that treatment is available, that you are eligible for a particular drug, or that you should travel. Those remain clinical and administrative decisions for the treating hospital.

Keep the distinction clear in your own mind: a review can tell you whether your case fits what a centre handles and what it would need to go further. It does not confirm access to a named medicine, a place on a clinical trial, or a treatment plan.

What the Centre Must Confirm Before You Plan Travel

If the records are sufficient for a review, the next questions are practical and specific. Can the centre assess this tumour type and this biomarker context? How would ongoing treatment be continued if you were already receiving a drug? How would monitoring be organised, and what would happen if a medicine were unavailable or unsuitable? These are questions for the treating team, not assumptions you should make from a general description of a hospital.

Ask directly whether the centre has experience with the specific drug class and biomarker you are asking about. Ask what it would need to see before confirming an appointment, and whether that appointment is a consultation only or part of a treatment pathway. Ask how a treatment decision would be communicated and who would be responsible for follow-up after you return home.

Medicine availability is a separate question from clinical suitability. If you are asking about a specific drug, ask the hospital whether it can be prescribed and supplied there, and ask the relevant authorities about bringing medicines into China if that applies to you. Those are not decisions a coordination service or a clinician abroad can make on your behalf.

Do not treat a positive preliminary reply as confirmation of treatment, cost, or timing. It is a signal that the conversation can continue with a clearer set of questions.

How to Send Records Without Losing the Thread

Start with a short summary rather than a complete archive. A one-page chronology of diagnosis, biomarker results, treatments to date and your main question gives the receiving team something to work with immediately. Attach the key reports behind it. This is faster to review than an unsorted folder and makes gaps visible.

Label every document with its date and source. If a report is in another language, ask whether a translation is needed and who should provide it. Keep original files as well as any translation. If a document is missing, say so explicitly in your summary rather than leaving the reader to notice the gap.

For an initial enquiry, a brief summary is enough. You do not need to send passport details, payment information or a complete medical archive at first contact. Once the centre has confirmed what it needs, you can share the specific documents through the channel it specifies.

If you would like help organising records, requesting a specialist appointment, or arranging interpretation during a hospital visit, ChinaSpecialistCare can coordinate those practical steps. The clinical assessment, suitability decision and treatment plan remain with the treating hospital and its licensed clinicians.

Related treatment reference

Your Next Step

Write your one-paragraph summary now: diagnosis, biomarker result if known, drugs already received with dates, your main question, and a list of the documents you have and the ones you cannot find. Send that short summary through the enquiry form, email or WhatsApp. An initial enquiry is free and does not require buying a proxy consultation.

If you are currently unwell or your symptoms are worsening, seek care where you are before pursuing an overseas enquiry. A records review is not emergency care and should not delay local assessment.

The most useful thing you can do is name the missing document precisely and ask the centre whether it changes what can be assessed. That single question turns an incomplete file into a clear next action.